| Product Code: ETC11390482 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Antiemetics Drugs Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Antiemetics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Antiemetics Drugs Market - Industry Life Cycle |
3.4 Japan Antiemetics Drugs Market - Porter's Five Forces |
3.5 Japan Antiemetics Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Japan Antiemetics Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan Antiemetics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Antiemetics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) in Japan |
4.2.2 Rising awareness about the benefits of antiemetic drugs in managing nausea and vomiting |
4.2.3 Growing geriatric population in Japan leading to higher demand for antiemetics |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for new antiemetic drugs in Japan |
4.3.2 Competition from alternative therapies such as acupuncture and herbal remedies |
5 Japan Antiemetics Drugs Market Trends |
6 Japan Antiemetics Drugs Market, By Types |
6.1 Japan Antiemetics Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Antiemetics Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Japan Antiemetics Drugs Market Revenues & Volume, By Serotonin Receptor Antagonists, 2021 - 2031F |
6.1.4 Japan Antiemetics Drugs Market Revenues & Volume, By Dopamine Antagonists, 2021 - 2031F |
6.1.5 Japan Antiemetics Drugs Market Revenues & Volume, By NK1 Receptor Antagonists, 2021 - 2031F |
6.2 Japan Antiemetics Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Antiemetics Drugs Market Revenues & Volume, By Chemotherapy-Induced Nausea, 2021 - 2031F |
6.2.3 Japan Antiemetics Drugs Market Revenues & Volume, By Motion Sickness, 2021 - 2031F |
6.2.4 Japan Antiemetics Drugs Market Revenues & Volume, By Post-Surgical Nausea, 2021 - 2031F |
6.3 Japan Antiemetics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Japan Antiemetics Drugs Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.3 Japan Antiemetics Drugs Market Revenues & Volume, By Online, 2021 - 2031F |
6.3.4 Japan Antiemetics Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
7 Japan Antiemetics Drugs Market Import-Export Trade Statistics |
7.1 Japan Antiemetics Drugs Market Export to Major Countries |
7.2 Japan Antiemetics Drugs Market Imports from Major Countries |
8 Japan Antiemetics Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for new antiemetic drugs in Japan |
8.2 Patient adherence rate to prescribed antiemetic medications |
8.3 Rate of adoption of antiemetic guidelines by healthcare providers |
9 Japan Antiemetics Drugs Market - Opportunity Assessment |
9.1 Japan Antiemetics Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Japan Antiemetics Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan Antiemetics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Antiemetics Drugs Market - Competitive Landscape |
10.1 Japan Antiemetics Drugs Market Revenue Share, By Companies, 2024 |
10.2 Japan Antiemetics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here